The findings of our study not only enhance our understanding of the molecular mechanisms of MMP/FasL COVID-19, but also pave the way for potential therapeutic interventions targeting the MMP7/MMP9 and FasL pathways. The gene discussed is FASLG; the disease is COVID-19.